Therefore, hepatocyte HIF-2α expression may not be a key factor in the initiation of liver fibrogenesis, and hepatocyte-specific deletion of HIF-2α may not be the ideal therapeutic strategy for liver fibrosis. This evidence concerns the gene EPAS1 and Hepatic fibrosis.